Details of the Drug | DrugMAP

General Information of Drug (ID: DMXX3EW)

Drug Name

INO-5401

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Phase 2	[1]
Recurrent glioblastoma	2A00.00	Phase 2	[1]
Glioblastoma of brain	2A00.00	Phase 1/2	[2]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: D0P2ME

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT03491683) INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM). U.S. National Institutes of Health.